As we recall last year, Arriello Ireland won Pharma Contract Services Company of the Year at the Pharma Industry Awards 2025, recognised for its outstanding contribution to clinical safety, regulatory excellence, and innovative outsourcing solutions across the pharmaceutical sector. 

Over the last year, Arriello has emerged as a trusted partner for cutting-edge biotech innovators in gene therapies and oncology, delivering high-quality, compliant outsourcing services while driving operational growth. Its approach combines exceptional client delivery with AI-powered innovation, robust GVP accreditation, and ISO QMS standards to ensure world-class performance and compliance.

“Arriello Ireland demonstrated a sophisticated, future-ready approach to clinical safety and regulatory excellence. Their integration of AI tools, proactive collaboration with global agencies, and strong client feedback highlight an organisation operating at the forefront of pharmaceutical outsourcing,” the judging panel noted.

Arriello’s recognition reflects the increasing standards across the Pharma Industry Awards, where winners are celebrated for combining technological innovation, operational precision, and measurable impact in client and patient outcomes. The company’s success illustrates how a forward-thinking, intelligence-led culture can elevate both service quality and industry benchmarks.

With momentum from the 2025 winners, attention now turns to the next awards cycle. Who will define the next era of excellence in pharmaceutical contract services, regulatory innovation, and clinical safety leadership for 2026?

The Pharma Industry Awards bring together senior executives, innovators, and decision-makers from across the life sciences sector to celebrate transformative achievements and leadership.

Visit the official awards website to explore past winners, read more about their achievements, and subscribe to the newsletter for updates on future awards and industry insights.